Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2004 Nov;6(6):443-50.
doi: 10.1007/s11886-004-0053-4.

Treatment of lipids and type 2 diabetes

Affiliations
Review

Treatment of lipids and type 2 diabetes

Kathie L Hermayer. Curr Cardiol Rep. 2004 Nov.

Abstract

The development of type 2 diabetes is increasing in epidemic proportions. There is a significant risk for cardiovascular disease, which is the most prevalent and detrimental complication for the diabetic population. Serum lipid abnormalities are common in patients with diabetes, and due to this increased vascular risk, it is recommended to aggressively treat the hyperlipidemia. Therefore, intensive lipid-lowering therapy should be used for primary and secondary prevention against macrovascular complications for patients with type 2 diabetes. In this article some of the key studies justifying the need for lipid reduction in patients with type 2 diabetes are reviewed and practical guidelines for management of the dyslipidemia are suggested.

PubMed Disclaimer

Similar articles

References

    1. Diabetes. 1999 Jun;48(6):1289-94 - PubMed
    1. Lancet. 2000 Jan 22;355(9200):253-9 - PubMed
    1. Am J Cardiol. 2002 Nov 15;90(10):1084-91 - PubMed
    1. J Intern Med. 1990 Aug;228(2):165-71 - PubMed
    1. JAMA. 1998 May 27;279(20):1615-22 - PubMed

MeSH terms

LinkOut - more resources